EVA1C
Basic information
Region (hg38): 21:32412006-32515397
Previous symbols: [ "C21orf64", "C21orf63", "FAM176C" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EVA1C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 27 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 2 | 3 |
Variants in EVA1C
This is a list of pathogenic ClinVar variants found in the EVA1C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-32412896-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
21-32412899-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
21-32412917-C-T | not specified | Uncertain significance (Oct 27, 2023) | ||
21-32412920-C-A | Likely benign (Jun 22, 2023) | |||
21-32412927-T-C | not specified | Uncertain significance (Sep 14, 2023) | ||
21-32412977-T-G | not specified | Uncertain significance (Feb 02, 2022) | ||
21-32412984-A-T | not specified | Uncertain significance (Jan 08, 2024) | ||
21-32453359-G-C | not specified | Uncertain significance (Apr 18, 2023) | ||
21-32453378-A-G | not specified | Uncertain significance (Aug 09, 2021) | ||
21-32453386-C-T | not specified | Uncertain significance (Jan 26, 2023) | ||
21-32453407-C-G | not specified | Uncertain significance (Jul 14, 2021) | ||
21-32457648-A-T | not specified | Uncertain significance (Feb 27, 2024) | ||
21-32457651-C-T | not specified | Uncertain significance (Apr 27, 2022) | ||
21-32457652-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
21-32467740-C-G | not specified | Uncertain significance (Mar 16, 2022) | ||
21-32467744-A-G | not specified | Uncertain significance (Apr 26, 2024) | ||
21-32467842-C-A | not specified | Uncertain significance (Oct 26, 2021) | ||
21-32467842-C-G | not specified | Uncertain significance (Jul 20, 2021) | ||
21-32467843-C-G | not specified | Uncertain significance (Mar 16, 2022) | ||
21-32495163-C-T | Benign (Jul 16, 2018) | |||
21-32495164-G-T | not specified | Uncertain significance (Aug 13, 2021) | ||
21-32501436-C-T | not specified | Uncertain significance (Sep 14, 2022) | ||
21-32503926-G-A | not specified | Uncertain significance (May 24, 2024) | ||
21-32503934-T-G | not specified | Uncertain significance (Jul 08, 2022) | ||
21-32504009-A-G | not specified | Uncertain significance (Jul 20, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EVA1C | protein_coding | protein_coding | ENST00000300255 | 8 | 103394 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00146 | 0.992 | 125726 | 0 | 20 | 125746 | 0.0000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.802 | 204 | 239 | 0.854 | 0.0000127 | 2851 |
Missense in Polyphen | 57 | 86.606 | 0.65815 | 1033 | ||
Synonymous | 0.644 | 91 | 99.2 | 0.918 | 0.00000562 | 856 |
Loss of Function | 2.40 | 8 | 19.4 | 0.413 | 9.03e-7 | 245 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000341 | 0.000336 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000708 | 0.0000703 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000132 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds heparin. {ECO:0000269|PubMed:19470522}.;
Intolerance Scores
- loftool
- rvis_EVS
- 0.17
- rvis_percentile_EVS
- 65.96
Haploinsufficiency Scores
- pHI
- 0.160
- hipred
- Y
- hipred_score
- 0.575
- ghis
- 0.517
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Eva1c
- Phenotype
- vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- biological_process
- Cellular component
- extracellular region;integral component of membrane
- Molecular function
- heparin binding;carbohydrate binding